Unveiling the challenges of short non-coding RNAs and their prospects in cancer therapy
Loganathan Chandramani Priya Dharshini,Abul Kalam Azad Mandal
DOI: https://doi.org/10.1016/j.jddst.2024.106411
IF: 5
2024-11-22
Journal of Drug Delivery Science and Technology
Abstract:Highlights • SncRNAs act as tumor suppressors or oncogenes, that can be regulated to silence gene expression in cells. • Off-target effects, poor delivery, immunogenicity, and limited stability are the challenges of sncRNA therapies. • Chemical modifications, nanotechnology, exosome-based delivery, and gene editing can aid in overcoming the challenges. • SncRNA therapies can potentially become a powerful new generation of cancer treatments. Short non-coding RNAs (sncRNAs) represent a burgeoning frontier in cancer therapeutics due to their exquisite gene regulatory abilities. These molecules hold immense potential for precisely targeting and manipulating gene expression in cancer cells. However, several key challenges limit their clinical application, effectively reducing sncRNAs function to specific targets within the body. This review delves into the emerging role of sncRNAs in gene regulation in cancer. We focus on the critical challenges linked with sncRNA, including ensuring their stability in circulation, minimizing off-target effects, optimizing tolerability within the patient, and facilitating efficient cellular uptake. In addressing significant research gaps, particularly the issues of stability, off-target effects, and the translational challenges from preclinical to clinical settings, this review highlights therapeutic strategies such as chemical modifications, novel delivery systems, gene editing techniques, and combination therapies with conventional treatments. By addressing these challenges and exploring these therapeutic strategies, sncRNA-based therapies hold the potential to significantly improve cancer treatment. Future research should focus on optimizing these strategies to translate preclinical findings into effective clinical applications. Graphical abstract This figure presents a comprehensive overview of the challenges, prospects, and strategies associated with delivering short non-coding RNAs (sncRNAs) for cancer therapy. It highlights the obstacles, such as poor cell penetration, immune system activation, renal clearance, etc., that must be overcome to effectively utilize sncRNAs in clinical settings. Additionally, the figure explores the potential benefits of sncRNA-based therapies and various delivery strategies, including nanotechnology and gene editing techniques, that are being developed to address these challenges. Overall, this figure provides a valuable resource for understanding the current landscape of sncRNA delivery and its potential applications in cancer treatment. Download: Download high-res image (402KB) Download: Download full-size image
pharmacology & pharmacy